Cytlink
Ordered peptides from Cytlink? Mail in a sample (US only) and let us test it.
Test my supplyCytlink's purity-focus record is thin and currently defined by Retatrutide, where repeated identity failures overwhelm any purity or fill signal. The October and November PharmLabs COAs point in the same weak direction, with batch detail limited enough that the vendor picture remains uncertain.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Cytlink rows.
Cancel anytime
| Date | Result | Test | Lab | Purity | Dosage | Label | COA |
|---|---|---|---|---|---|---|---|
6 Nov 2026 | Fail | Retatrutide Cytlink | lab name | View COA | |||
15 Oct 2026 | Fail | Retatrutide Cytlink | lab name | View COA | |||
About Cytlink test results from Finnrick
Cytlink is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 1 peptide and 2 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Cytlink peptides in this dataset are Retatrutide (2 tests), Tirzepatide (0 tests) and Ipamorelin (0 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 2 recent tests.
Ordered peptides from Cytlink? Mail in a sample (US only) and let us test it.
Test my supply